Medical Marketing & Media2d
Rx Rundown: Merck, Novo Nordisk, GSK and more
Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.
Petri Dish: Late-stage cancer trial halt; Dyne names CFO
A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...
2025 ISPE Biotechnology Conference Announces Keynote Speakers
The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in ...
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated ...
Fernández Alcalde takes the reins at EMD Serono, one of Boston’s newest biotechs
Plus: JetBlue CEO eyes more growth in Boston; AG Andrea Campbell offers fiery words about Trump; Charles River chamber offers ...